Longitudinal changes of plasma HVA and 5-HIAA levels in schizophrenic patients resistant to neuroleptics

Luisella Bocchio‐Chiavetto; Stefano Bignotti; G.B. Tura; Michael Maes; Rosaria Pioli; Carlo Altamura; Giorgio Racagni

doi:10.1016/s0924-977x(99)80297-1

Discussion(0)

No comments yet. Be the first to comment.

Related publications

Article2000

Effects of atypical antipsychotics on the inflammatory response system in schizophrenic patients resistant to treatment with typical neuroleptics

Michael Maes

Corrigendum2016

Erratum to: C3 Polymorphism Influences Circulating Levels of C3, ASP and Lipids in Schizophrenic Patients

Mohamed Jalloul Nsaibia, Marc Lapointe, H. Mabrouk, Wahiba Douki, L. Gaha, Louis Pérusse, Claude Bouchard, Besma Bel Hadj Jrad, Katherine Cianflone

Article1997

Immune modulation in resistant schizophrenic patients during long-term neuroleptic treatment

Stefano Bignotti, G.B. Tura, Giuseppe Rossi, R. Pioli, Michael Maes, A.C. Altamura

Article2015

C3 Polymorphism Influences Circulating Levels of C3, ASP and Lipids in Schizophrenic Patients

Mohamed Jalloul Nsaiba, Marc Lapointe, H. Mabrouk, Wahiba Douki, L. Gaha, Louis Pérusse, Claude Bouchard, Besma Bel Hadj Jrad, Katherine Cianflone

Neurochemical Research

Article2021

Longitudinal clinical, cognitive, and neuroanatomical changes over 5 years in GBA-positive Parkinson’s disease patients

Michela Leocadi, Elisa Canu, Giulia Donzuso, Tanja Stojković, Silvia Basaia, Nikola Kresojević, Iva Stanković, Elisabetta Sarasso, Noemi Piramide, Aleksandra Tomić, Vladana Marković, Igor Petrović, Elka Stefanova, Vladimir Kostić, Massimo Filippi, Federica Agosta